Similar articles

• S 18126 ([2-[4-(2,3-dihydrobenzo[1,4]dioxin-6-yl)piperazin-1-yl methyl]indan-2-yl]), a potent, selective and competitive antagonist at dopamine D4 receptors: an in vitro and in vivo comparison with L 745,870 (3-(4-[4-chlorophenyl]piperazin-1-yl)methyl-1H-pyrrolo[2, 3b]pyridine) and raclopride.

  Millan MJ, Newman-Tancredi A, Brocco M, Gobert A, Lejeune F, Audinot V, Rivet JM, Schreiber R, Dekeyne A, Spedding M, Nicolas JP, Peglion JL. Millan MJ, et al. J Pharmacol Exp Ther. 1998 Oct;287(1):167-86. J Pharmacol Exp Ther. 1998. PMID: 9765336
• (S)-(-)-4-[4-[2-(isochroman-1-yl)ethyl]-piperazin-1-yl] benzenesulfonamide, a selective dopamine D4 antagonist.

  TenBrink RE, Bergh CL, Duncan JN, Harris DW, Huff RM, Lahti RA, Lawson CF, Lutzke BS, Martin IJ, Rees SA, Schlachter SK, Sih JC, Smith MW. TenBrink RE, et al. J Med Chem. 1996 Jun 21;39(13):2435-7. doi: 10.1021/jm960084f. J Med Chem. 1996. PMID: 8691438 No abstract available.
• L-745,870, a subtype selective dopamine D4 receptor antagonist, does not exhibit a neuroleptic-like profile in rodent behavioral tests.

  Bristow LJ, Collinson N, Cook GP, Curtis N, Freedman SB, Kulagowski JJ, Leeson PD, Patel S, Ragan CI, Ridgill M, Saywell KL, Tricklebank MD. Bristow LJ, et al. J Pharmacol Exp Ther. 1997 Dec;283(3):1256-63. J Pharmacol Exp Ther. 1997. PMID: 9400001
• [Functional role of dopamine D4 receptor in schizophrenia].

  Semba J. Semba J. Nihon Shinkei Seishin Yakurigaku Zasshi. 2004 Feb;24(1):13-20. Nihon Shinkei Seishin Yakurigaku Zasshi. 2004. PMID: 15027326 Review. Japanese.
• Dopamine D3 and D4 receptor antagonists in the treatment of schizophrenia.

  Jardemark K, Wadenberg ML, Grillner P, Svensson TH. Jardemark K, et al. Curr Opin Investig Drugs. 2002 Jan;3(1):101-5. Curr Opin Investig Drugs. 2002. PMID: 12054059 Review.